Inhibitory effect of schizophyllan on rat glioma cells

Authors

  • Bin Zhou Department of Neurosurgery, the Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250001
  • Qiang Fu Department of Neurosurgery, Liaocheng People's Hospital, Liaocheng 252002
  • Sha-Sha Song Department of Pathology, Ji'nan Central Hospital Affiliated to Shandong University, Jinan 250100
  • Hong-Li Zheng Department of Neurosurgery, people's Hospital of Haiyang City, Haiyang 265100
  • Yu-Zhen Wei Department of Neurosurgery, Jining No.1 People?s Hospital, Jining 272011 http://orcid.org/0000-0003-1032-9451

Keywords:

Glioma cell, Rat, Schizophyllan

Abstract

The aim of this study was to examine the anticancer effects of schizophyllan (a -D-glucan) against the growth of rat CNS-1 glioma cells and preliminarily assess its effect on inducing apoptosis and blocking cell cycle. In order to evaluate its inhibitory effect, firstly MTT assay was conducted followed by annexin V/propidium iodide double staining or propidium iodide single staining, apoptosis and cell cycle using flow cytometry. All the experiments were carried in a dose- and time-dependent manner. Experimental results showed that treatment of 40 and 60 mg/L schizophyllan significantly increased the apoptotic rate and blocked the cell cycle. In addition, increase in the proportion of cells in G0/G1 phase and decrease in the proportion of S-phase cells were also observed. Overall experimental studies suggest that schizophyllan can significantly inhibit the growth of rat CNS-1 glioma cells, in vitro and induced apoptosis and blocked the cell cycle.

Abstract
528
Download
418 Read
257

Downloads

Additional Files

Published

2015-09-23

How to Cite

Zhou, Bin, et al. “Inhibitory Effect of Schizophyllan on Rat Glioma Cells”. Bangladesh Journal of Pharmacology, vol. 10, no. 4, Sept. 2015, pp. 759-64, https://doi.org/10.3329/bjp.v10i4.23834.

Issue

Vol. 10 No. 4 (2015)

Section

Research Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

How to Cite

Zhou, Bin, et al. “Inhibitory Effect of Schizophyllan on Rat Glioma Cells”. Bangladesh Journal of Pharmacology, vol. 10, no. 4, Sept. 2015, pp. 759-64, https://doi.org/10.3329/bjp.v10i4.23834.